In this study, we sought to investigate the role of MSMP/CCR2 signaling in macrophage polarization and the effects of targeting CCR2+ macrophages with bromodomain and extra-terminal domain (BET) inhibitors (BETi) in ovarian cancer, especially in the context of enhancing the efficacy of AVA therapy. This evidence concerns the gene CCR2 and ovarian cancer.